Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Fiona Powrie, Director of the Kennedy Institute has been awarded an honorary degree of Doctor of Science from the University of Bath.

A Bath alumna, Professor Powrie has dedicated her career to better understanding the human gut and its interactions with the immune system, and her work is opening up new avenues for the treatment of chronic intestinal inflammatory diseases.

Her research focuses on the role of immune pathways in the intestine in health and how these change in inflammatory bowel disease. She identified cells that police the immune response in the intestine – regulatory T cells (Treg) – and prevent our defence system from attacking bacteria that are good for the human body; she has also demonstrated that Treg cell deficiencies could lead to chronic intestinal inflammatory disease.

Speaking of her award, Professor Powrie said: “It is a great honour for me to receive an Honorary degree from the University of Bath. It was as a Bath biochemistry undergraduate that I first became interested in the immune system and was inspired to follow a career in academic research.”

The University of Bath is one of the UK's leading universities both in terms of research and reputation for excellence in teaching, learning and graduate prospects. Its honorary degrees are prestigious awards conferred to individuals who have made significant contributions in their field.

A Fellow of the Royal Society since 2011, Professor Powrie has also received numerous other distinctions, notably the 2012 Louis-Jeantet Prize for Medicine, a major European award recognising excellence in biomedical research, as well as the 2009 Ita Askonas Prize, from the European Federation of Immunological Societies (EFIS) and the European Journal of Immunology (EJI), which is awarded to leading female immunologists.

Fiona Powrie studied biochemistry at the University of Bath before undertaking a PhD in immunology in Oxford. Following postdoctoral studies in the United States at the DNAX Research Institute, she returned to Oxford in 1996 to establish her own laboratory as a Wellcome Trust Senior Research Fellow.  She was appointed as the inaugural Sidney Truelove Professor of Gastroenterology at the University of Oxford in 2009 and established the Translational Gastroenterology Unit, Oxford.

In October 2014, Professor Powrie was appointed as Director of the Kennedy Institute of Rheumatology where she aims to translate fundamental basic science into new treatments for debilitating conditions such as inflammatory bowel disease and rheumatoid arthritis.

 

Watch the Ceremony video here (about minute 55).
Read the profiles of all Honorary Graduates here.

Images copyright: Nic Delves-Broughton, University of Bath 2015

Similar stories

NDORMS researchers win prestigious national leadership prizes

Professor of Orthopaedic Trauma Matthew Costa and NIHR Doctoral Research Fellow Rachel Kuo were announced among the winners of the NIHR20 Research Leaders Prizes in recognition of their outstanding contribution to health and care research.

From Paraguay to Oxford: Mariela’s experience of the Trueta Bursary

Mariela Ortiz, a pharmacist from Paraguay received a Trueta Bursary to attend the Botnar Institute's Summer School in Real World Evidence this June.

Arthritis origins may begin before birth, study finds

Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.

NDORMS student wins national research prize

A medical student at NDORMS has gained a top prize in the prestigious 2026 Falk Foundation/Guts UK Charity national awards. Sara Lyden won the Medical Student Prize for her research project, ‘Integrating histo-molecular patient profiles with patient reported symptoms and quality of life measures in ulcerative colitis.’

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.

NDORMS team wins Award for Excellence for transforming ulcerative colitis care

The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.